We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

First Patient Dosed in Phase II Clinical Trial of NKTR-102 in Ovarian Cancer

News   Jan 14, 2009

 
First Patient Dosed in Phase II Clinical Trial of NKTR-102 in Ovarian Cancer
 
 
 

RELATED ARTICLES

More Effective Drug Combination Regimens to Treat TB Faster

News

UCLA researchers have identified a way to significantly reduce the duration of tuberculosis treatment using an approach called "artificial intelligence-parabolic response surface."

READ MORE

“Metabolic Fingerprint” Could Help Treat, Diagnose and Prevent Cervical Cancer

News

Researchers at the University of Arizona have completed the first-of-its-kind study that could aid in the treatment, diagnosis and prevention of cervical cancer by identifying cervicovaginal metabolic signatures, or "fingerprints" that distinguish patients with HPV, pre-cancerous cervical conditions and cancer.

READ MORE

A Closer Look at How the Brain Controls Food Intake

News

Regardless of how much you exercise or how balanced your diet is, controlling your weight is more brain-related than you might have thought. In a recent study, researchers show for the first time in mice that the acyl-CoA-binding protein, or ACBP, has a direct influence on the neurons that allow rodents and humans to maintain a healthy weight.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE